Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP683414.RAL6ajwLdo0FRPHwRdTUKPCteHyvZm1-XPZ2fBKvpC71g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP683414.RAL6ajwLdo0FRPHwRdTUKPCteHyvZm1-XPZ2fBKvpC71g130_assertion type Assertion NP683414.RAL6ajwLdo0FRPHwRdTUKPCteHyvZm1-XPZ2fBKvpC71g130_head.
- NP683414.RAL6ajwLdo0FRPHwRdTUKPCteHyvZm1-XPZ2fBKvpC71g130_assertion description "[Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP683414.RAL6ajwLdo0FRPHwRdTUKPCteHyvZm1-XPZ2fBKvpC71g130_provenance.
- NP683414.RAL6ajwLdo0FRPHwRdTUKPCteHyvZm1-XPZ2fBKvpC71g130_assertion evidence source_evidence_literature NP683414.RAL6ajwLdo0FRPHwRdTUKPCteHyvZm1-XPZ2fBKvpC71g130_provenance.
- NP683414.RAL6ajwLdo0FRPHwRdTUKPCteHyvZm1-XPZ2fBKvpC71g130_assertion SIO_000772 19549232 NP683414.RAL6ajwLdo0FRPHwRdTUKPCteHyvZm1-XPZ2fBKvpC71g130_provenance.
- NP683414.RAL6ajwLdo0FRPHwRdTUKPCteHyvZm1-XPZ2fBKvpC71g130_assertion wasDerivedFrom befree-20150227 NP683414.RAL6ajwLdo0FRPHwRdTUKPCteHyvZm1-XPZ2fBKvpC71g130_provenance.
- NP683414.RAL6ajwLdo0FRPHwRdTUKPCteHyvZm1-XPZ2fBKvpC71g130_assertion wasGeneratedBy ECO_0000203 NP683414.RAL6ajwLdo0FRPHwRdTUKPCteHyvZm1-XPZ2fBKvpC71g130_provenance.